BrainStorm by UsAgainstAlzheimer's
BrainStorm by UsAgainstAlzheimer's
Meryl Comer, UsAgainstAlzheimer's
Ep 99: The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)
16 minutes Posted Dec 2, 2025 at 5:00 am.
0:00
16:32
Download MP3
Show notes
BrainStorm wants to hear from you! Send us a text. Ep 99: The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials. Dwyer shares how the field is shifting toward earlier intervention and leveraging artificial intelligence to improve trial efficiency and accuracy. AI ca...